Amerisourcebergen Stock

Amerisourcebergen EBIT Margin

The EBIT Margin (Operating Margin) of Amerisourcebergen (ABC) as of Aug 15, 2026 is 0.99 %. In the previous year, EBIT Margin (Operating Margin) was 1.10 % — a change of -9.85% (lower).

EBIT Margin

0.99 %

YoY

-9.85%

Last updated:

EBIT Margin (Operating Margin) of Amerisourcebergen is 2026 0.99 % . EBIT Margin (Operating Margin) of Amerisourcebergen was 2025 1.10 % . It decreases by -9.85% lower compared to the previous year.

For Amerisourcebergen, the operating (EBIT) margin of 1.0% is broadly stable versus 0.9% a few years ago.

Access this data via the Eulerpool API

Amerisourcebergen Stock analysis

What does Amerisourcebergen do? AmerisourceBergen Corp is a global healthcare company that offers a variety of products and services to its customers. It was founded in 2001 through the merger of AmeriSource Health Corp and Bergen Brunswig Corp. The company's business model is based on providing products, services, and technologies for various areas of the healthcare industry, including pharmacy, biotechnology, healthcare services, and retail. AmerisourceBergen Corp has three main business segments: Pharmaceutical Distribution Services, Provider Services, and Pharmaceutical Manufacturer Services. The pharmaceutical distribution service provides fast and reliable delivery of drugs and medical devices to pharmacies, wholesalers, and healthcare facilities. The provider service helps patients get the right medications and offers clinical services to medical facilities. The pharmaceutical manufacturer distribution provides support to its customers in the manufacturing, quality control, and marketing of drugs. The company also offers technology solutions that enable more patient-centered care and improve communication between doctors and patients. AmerisourceBergen Corp has extensive experience and expertise in the industry. It operates a wide network of branches and logistics centers worldwide to ensure its customers always receive the products and services they need. The company offers a wide range of pharmaceutical products, specialized disease drugs, biosimilars, vaccines, and medical devices. It also provides services such as consulting on drug manufacturing and approval, as well as logistics, financial, marketing, and information technology services for its customers. Over the years, AmerisourceBergen Corp has received numerous awards for its outstanding performance in the healthcare industry. The company is known for its commitment to patient-centered care and its innovative solutions to healthcare supply chain issues. With a strong reputation for quality and customer satisfaction, AmerisourceBergen Corp remains one of the leading companies in the healthcare industry. Amerisourcebergen is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Amerisourcebergen stock

EBIT Margin (Operating Margin) of Amerisourcebergen is 0.99 % in 2026.

EBIT Margin (Operating Margin) of Amerisourcebergen changed from 1.10 % to 0.99 %, representing a -9.85% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBIT Margin (Operating Margin) Amerisourcebergen since 2006 – with annual values, charts, and detailed analysis.

EBIT Margin measures operating profitability as a percentage of revenue. It shows how much profit a company makes from operations before interest and taxes.

A 'good' varies by industry and company stage. On Eulerpool, you can compare EBIT Margin (Operating Margin)'s Amerisourcebergen with sector peers and the industry average to assess whether it is attractive.

To evaluate EBIT Margin (Operating Margin)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EBIT Margin (Operating Margin).

Access this data via the Eulerpool API

Margins — Amerisourcebergen

All Key Metrics — Amerisourcebergen